CEO and President of RXi Pharmaceuticals Corp. (RXII, Financial) Noah D Beerman buys 10,000 shares of RXII on 07/09/2010 at an average price of $2.23 a share.
Rxi Pharmaceuticals Corp. has a market cap of $42.63 million; its shares were traded at around $2.32 .
Rxi Pharmaceuticals Corp. has a market cap of $42.63 million; its shares were traded at around $2.32 .
Directors and Officers Recent Trades:
- Sell: 10% Owner Corp Cytrx sold 2,000,000 shares of RXII stock on 06/30/2010 at the average price of 2.55. Corp Cytrx owns at least 3,093,881 shares after this. The price of the stock has decreased by 9.02% since.
- Sell: VP, Technology Development Dmitry Samarsky sold 4,081 shares of RXII stock on 03/31/2010 at the average price of 4.65. The price of the stock has decreased by 50.11% since.
- Sell: Director Sanford Hillsberg sold 25,000 shares of RXII stock on 03/26/2010 at the average price of 5.66. Sanford Hillsberg owns at least 6,000 shares after this. The price of the stock has decreased by 59.01% since.
- Sell: Director Stephen S Galliker sold 15,000 shares of RXII stock on 03/26/2010 at the average price of 5.54. Stephen S Galliker owns at least 10,000 shares after this. The price of the stock has decreased by 58.12% since.
